Skip to main content

Military Health System

Brief Report: Prevalence of Hepatitis C Virus Infections in U.S. Air Force Basic Military Trainees Who Donated Blood, 2017–2020

Image of 2_HCVblood donors. 2_HCVblood donors

Recommended Content:

Medical Surveillance Monthly Report

Background

Chronic infection with hepatitis C virus (HCV) can cause significant morbidity to individuals due to inflammatory damage to the liver. This chronic inflammatory damage can lead to further complications, including cirrhosis, hepatocellular carcinoma, and fulminant liver failure. In the military, HCV presents a concern for fitness for duty, readiness, and health care costs of its members.

In the U.S., prevalence of chronic HCV infection is approximately 1%.1 From 2010–2019, estimated annual acute HCV incidence increased 387%2; increased detection was driven at least in part by improved and expanded testing recommendations as well as increased injection drug use within the opioid abuse epidemic.3,4 During this timeframe, the majority of new HCV infections occurred in those aged 20–39 (which approximates the ages of those joining the military).2

In 2020, the American Association for the Study of Liver Diseases (AASLD),5 U.S. Preventive Services Task Force (USPSTF),6 and Centers for Disease Control and Prevention (CDC)7 expanded recommendations for HCV infection screening to include all adults age 18 years or older (and for all pregnant women during each pregnancy) because of cost effectiveness, limited success of risk-based screening, and availability of curative treatment.

Active HCV infection disqualifies an individual from military accession because its proper clinical management conflicts with initial training and mission readiness. Three disqualifying criteria for active or recent HCV infection include: history of chronic HCV without successful treatment or without documentation of cure 12 months after completion of a full course of therapy; acute infection within the preceding 6 months; or persistence of symptoms or evidence of impaired liver function. Force screening for HCV is not currently performed during U.S. Air Force (USAF) Basic Military Training (BMT) although screening is completed for other viral infections (including HIV, hepatitis A, and hepatitis B). As a result, the true prevalence of chronic HCV infection cannot be ascertained in the basic trainee population. However, the prevalence can be estimated based on the number of HCV infections confirmed following positive screening during trainee blood donations.

Trainees voluntarily donate blood near the end of BMT and are thus able to donate only once while at BMT. Concurrent testing for HCV antibody and HCV RNA occurs at the time of blood donation. If a trainee's blood tests positive for HCV antibody but negative for HCV RNA, a third generation enzyme immunoassay (EIA) is used for confirmation. A positive test for HCV antibody in addition to either a positive HCV RNA or EIA test indicates active infection. Alternatively, a positive HCV antibody test in an individual with negative RNA and EIA tests typically denotes a cleared infection.

From Nov. 2013 through April 2016, the estimated prevalence of HCV infection among volunteer recruit blood donors at Joint Base San Antonio (JBSA)-Lackland Blood Donor Center was 0.007%.8 The goal of this inquiry was to estimate the most recent prevalence of HCV infections within the USAF basic training population during 2017–2020.

Methods

The JBSA-Lackland Blood Donor Center was queried for the results of HCV screening for all basic military trainees who donated blood between Jan. 1, 2017 and Dec. 31, 2020. All other blood donations (those from individuals other than basic trainees) during this time period were excluded. HCV prevalence in those who donated blood was calculated using the total trainee donations as the denominator. Since trainees are only able to donate once before departing BMT, these donations represent unique trainees. The numerator included those who screened positive upon donation and were also confirmed to have active infection upon subsequent testing. Positive HCV cases were ascertained from a local database, which included demographic, diagnostic, and laboratory data for all USAF recruits, maintained by Trainee Health Surveillance. This database was queried for International Classification of Diseases, 10th Revision (ICD-10) diagnostic codes K70–K77 (diseases of the liver) and B15–B19 (viral hepatitis); the codes for all hepatitides were initially utilized so as to conduct a wide search in case of coding errors. A possible case was defined as a trainee receiving a qualifying ICD-10 code in any diagnostic position during an outpatient medical encounter and was restricted to 1 case per person during the surveillance period. The electronic medical records of possible cases were reviewed and those diagnosed with current HCV infection due to blood screening from BMT blood donation were counted as true cases. Such screened positive BMT cases were confirmed by comparing them to those reported by the Blood Donation Center. The Fisher's exact test for count data was used to compare the prevalence computed for the period from 2017 through 2020 to the prevalence during the period from 2013 through 2016.

Results

From 2017 through 2020, 29,615 unique individual trainees from USAF BMT donated blood (out of 146,325 total trainees attending BMT during that time) and had their blood donations screened for HCV. From this group, a total of 85 individuals screened positive for HCV antibodies; of these, 6 were confirmed to be positive for active HCV infection (positive HCV RNA or EIA) (Table). The prevalence of HCV in those BMT trainees who were screened from 2017 through 2020 was 0.0203% (6 of 29,615 screened) (data not shown), which is 3.1 times (p=.173) the prevalence of HCV infection in this population during 2013–2016 (0.0065%, 2 of 30,660 screened).8 Of note, during 2017–2020, one additional case of HCV in BMT was diagnosed clinically based on symptoms; however, this case was excluded in the prevalence calculation because it was not from a blood donation.

Editorial Comment

The prevalence of HCV infection in BMT trainee blood donors from 2017 through 2020 was 3.1 times the prevalence among trainees who donated from 2013 through 2016.8 While the difference in prevalence was not statistically significant (p=.173), it may reflect the recent increases in incidence among U.S. young adults, as noted by the CDC,2 perhaps due to increased injection drug use.3,4

This study is limited in that the screened blood came from only those trainees attempting to donate blood, so the data do not directly estimate HCV prevalence for all trainees as would be the case from a random sample of the entire BMT trainee population. If the prevalence in blood donors reflected that in basic trainees overall, there would have been approximately 30 active HCV infections among basic trainees during the 4 year period; and of these, only approximately 20% were detected through blood donor screening.

Instituting accession-wide HCV screening at USAF BMT by adding it to the current lab evaluation would be an efficient method of ensuring that all new USAF enlisted service members are up to date on this screening as recommended by USPSTF, CDC, and AASLD.

Author affiliations: 559th Trainee Health Squadron, JBSA-Lackland, TX (Maj Kasper, Capt Holland, and Maj Kieffer); Office of the Command Surgeon, Air Education and Training, JBSA-Randolph, TX (Maj Frankel); 59th Medical Wing, Science and Technology, JBSA-Lackland, TX (Ms. Cockerell); Air Force Medical Readiness Agency, Falls Church, VA (Lt Col Molchan).

Disclaimer: The views expressed are those of the authors and do not reflect the official views or policy of the Department of Defense or its Components. In addition, the opinions expressed on this document are solely those of the authors and do not represent endorsement by or the views of the United States Air Force, the Department of Defense, or the United States Government.

References

  1. Hofmeister MG, Rosenthal EM, Barker LK, et al. Estimating prevalence of hepatitis C virus infection in the United States, 2013–2016. Hepatology. 2019;69(3):1020–1031.
  2. Centers for Disease Control and Prevention. 2019 Viral Hepatitis Surveillance Report- Hepatitis C. Published July 2021. Accessed 9 Aug. 2021. https://www.cdc.gov/hepatitis/statistics/2019surveillance/HepC.htm
  3. Zibbell JE, Asher AK, Patel RC, et al. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108(2):175–181.
  4. Suryaprasad AG, White JZ, Xu F, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012. Clin Infect Dis. 2014;59(10):1411–1419.
  5. Ghany MG, Morgan TR; AASLD-IDSA Hepatitis C Guidance Panel. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases – Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology. 2020;71(2):686–721.
  6. US Preventive Services Task Force; Owens DK, Davidson KW, et al. Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020;323(10):970–975.
  7. Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC Recommendations for hepatitis C screening among adults - United States, 2020. MMWR Recomm Rep. 2020;69(2):1–17.
  8. Taylor DF, Cho RS, Okulicz JF, Webber BJ, Gancayco JG. Brief report: Prevalence of hepatitis B and C virus infections in U.S. Air Force basic military trainees who donated blood, 2013-2016. MSMR. 2017;24(12):20–22.

TABLE. Demographics and disposition of the 6 confirmed HCV cases identified through blood donation screening at Air Force Basic Military Training, 2017–2020

You also may be interested in...

Surveillance Snapshot: Norovirus Outbreaks in Military Forces, 2015–2019

Article
8/1/2020
Based on electron microscopic imagery, this three-dimensional illustration provides a graphical representation of a single norovirus virion. Though subtle, the different colors represent different regions of the organism’s outer protein shell, or capsid (Content provider: CDC/Jessica A. Allen; Photo credit: CDC/Alissa Eckert).

Surveillance Snapshot: Norovirus Outbreaks in Military Forces, 2015–2019

Recommended Content:

Medical Surveillance Monthly Report

Update: Incidence of Acute Gastrointestinal Infections and Diarrhea, Active Component, U.S. Armed Forces, 2010–2019

Article
8/1/2020
This illustration was updated in the Centers for Disease Control and Prevention’s (CDC’s) Antibiotic Resistance Threats in the United States, 2019. This illustration depicts a three-dimensional, computer-generated image of a group of extended-spectrum ß-lactamase-producing Enterobacteriaceae bacteria, in this case, Escherichia coli. The artistic recreation was based upon scanning electron microscopic imagery. This is an excellent visual example of the long, whip-like, peritrichous flagellae, sprouting from what appear to be random points on the organism’s exterior, as well as the numerous shorter, and finer fimbriae, imparting a furry look to the bacteria (Content provider: CDC/Antibiotic Resistance Coordination and Strategy Unit; Photo credit:  CDC/Alissa Eckert).

Update: Incidence of Acute Gastrointestinal Infections and Diarrhea, Active Component, U.S. Armed Forces, 2010–2019

Recommended Content:

Medical Surveillance Monthly Report

Surveillance Snapshot: Cervical Cancer Screening Among U.S. Military Service Women in the Millennium Cohort Study, 2003–2015

Article
7/1/2020
Lt. Cmdr. Leslye Green, staff obstetrician and gynecologist, Naval Hospital Pensacola (NHP), uses a model to discuss cervical cancer with a patient at NHP. According to the Centers for Disease Control and Prevention (CDC), cervical cancer is highly preventable because screening tests for cervical cancer and vaccines to protect against human papillomavirus (HPV), which is the main cause of cervical cancer, are readily available. Cervical cancer is highly treatable and associated with long survival and good quality of life when it is detected early. (U.S. Navy photo by Mass Communication Specialist 1st Class Brannon Deugan)

Surveillance Snapshot: Cervical Cancer Screening Among U.S. Military Service Women in the Millennium Cohort Study, 2003–2015

Recommended Content:

Medical Surveillance Monthly Report

Hearing Conservation Measures of Effectiveness Across the Department of Defense

Article
7/1/2020
Kori Reese, an audiology technician at Naval Branch Health Clinic Jacksonville’s occupational health clinic, conducts a hearing exam with Airman Diosney Moraga. Naval Hospital Jacksonville and Navy Medical Readiness and Training Command Jacksonville won the Chief of Naval Operation’s Award for Achievement in Ashore Safety (large non-industrial command) for Fiscal Year 2019. (U.S. Navy photo by Jacob Sippel).

Recommended Content:

Medical Surveillance Monthly Report

Epidemiology of Functional Neurological Disorder, Active Component, U.S. Armed Forces, 2000-2018

Article
7/1/2020
MRI film (iStock.com/temet)

Epidemiology of Functional Neurological Disorder, Active Component, U.S. Armed Forces, 2000-2018

Recommended Content:

Medical Surveillance Monthly Report

Alcohol-Related Emergency Department Visits, Hospitalizations, and Co-Occurring Injuries, Active Component, U.S. Armed Forces, 2009–2018

Article
7/1/2020
Sailors simulate a drunk driving accident during a Keep What You've Earned fair on Naval Base Kitsap Bangor. The fair encourages responsible alcohol use by celebrating the achievements in the sailors' Navy careers and actively engages sailors as advocates for responsible drinking. (U.S. Navy photo by Mass Communication Specialist 3rd Class Chris Brown)

Recommended Content:

Medical Surveillance Monthly Report

Animal-Related Injuries in Veterinary Services Personnel, U.S. Army, 2001–2018

Article
6/1/2020
04_vet_DVIDS

Recommended Content:

Medical Surveillance Monthly Report

Summary of the 2018–2019 Influenza Season Among Department of Defense Service Members and Other Beneficiaries

Article
6/1/2020
02_flu shot_DVIDS

Recommended Content:

Medical Surveillance Monthly Report

Letter to the Editor: G6PD Deficiency in the Tafenoquine Era

Article
6/1/2020
A funestus_James Gathany

Letter to the Editor: G6PD Deficiency in the Tafenoquine Era

Recommended Content:

Medical Surveillance Monthly Report

Brief Report: Direct Care Cost of Heat Illness to the Army, 2016–2018

Article
6/1/2020
03_heat illness_army_560740

Brief Report: Direct Care Cost of Heat Illness to the Army, 2016–2018

Recommended Content:

Medical Surveillance Monthly Report

Surveillance Snapshot: Illness and Injury Burdens, Recruit Trainees, Active Component, U.S. Armed Forces, 2019

Article
5/1/2020
05Recruits snapshotmedia defensegov

Recommended Content:

Medical Surveillance Monthly Report

Special Report: Prevalence of Selected Underlying Health Conditions Among Active Component Army Service Members with Coronavirus Disease 2019, 11 February–6 April 2020

Article
5/1/2020
09 and 10_USS Comfort_Navy website

Recommended Content:

Medical Surveillance Monthly Report

Absolute and Relative Morbidity Burdens Attributable to Various Illnesses and Injuries, Non-service Member Beneficiaries of the Military Health System, 2019

Article
5/1/2020
08_NonSM beneficiaries_DVIDS

Recommended Content:

Medical Surveillance Monthly Report

Special Report: Early Use of ICD-10-CM Code “U07.1, COVID-19” to Identify 2019 Novel Coronavirus Cases in Military Health System Administrative Data

Article
5/1/2020
09 and 10_USS Comfort_Navy website

Recommended Content:

Medical Surveillance Monthly Report

Ambulatory Visits, Active Component, U.S. Armed Forces, 2019

Article
5/1/2020
03_ambulatory_listening chest_scaled

Recommended Content:

Medical Surveillance Monthly Report
<< < ... 6 7 8 9 10  ... > >> 
Showing results 121 - 135 Page 9 of 15
Refine your search
Last Updated: October 18, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery